Insuline Medical (Israel) Probability of Future Stock Price Finishing Over 206.62
| INSL Stock | ILS 210.00 8.00 3.96% |
Insuline |
Insuline Medical Target Price Odds to finish over 206.62
The tendency of Insuline Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above S 206.62 in 90 days |
| 210.00 | 90 days | 206.62 | over 95.35 |
Based on a normal probability distribution, the odds of Insuline Medical to stay above S 206.62 in 90 days from now is over 95.35 (This Insuline Medical probability density function shows the probability of Insuline Stock to fall within a particular range of prices over 90 days) . Probability of Insuline Medical price to stay between S 206.62 and its current price of S210.0 at the end of the 90-day period is about 1.52 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.99 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Insuline Medical will likely underperform. Additionally Insuline Medical has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Insuline Medical Price Density |
| Price |
Predictive Modules for Insuline Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Insuline Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Insuline Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Insuline Medical is not an exception. The market had few large corrections towards the Insuline Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Insuline Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Insuline Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.57 | |
β | Beta against Dow Jones | 1.99 | |
σ | Overall volatility | 24.25 | |
Ir | Information ratio | -0.09 |
Insuline Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Insuline Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Insuline Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Insuline Medical generated a negative expected return over the last 90 days | |
| Insuline Medical has high historical volatility and very poor performance | |
| The company has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Insuline Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Insuline Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Insuline Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Insuline to invest in growth at high rates of return. When we think about Insuline Medical's use of debt, we should always consider it together with cash and equity. | |
| Insuline Medical reported the revenue of 40 K. Net Loss for the year was (7.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Insuline Medical has accumulated about 1.15 M in cash with (7.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.86. |
Insuline Medical Technical Analysis
Insuline Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Insuline Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Insuline Medical. In general, you should focus on analyzing Insuline Stock price patterns and their correlations with different microeconomic environments and drivers.
Insuline Medical Predictive Forecast Models
Insuline Medical's time-series forecasting models is one of many Insuline Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Insuline Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Insuline Medical
Checking the ongoing alerts about Insuline Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Insuline Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Insuline Medical generated a negative expected return over the last 90 days | |
| Insuline Medical has high historical volatility and very poor performance | |
| The company has a current ratio of 0.96, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Insuline Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Insuline Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Insuline Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Insuline to invest in growth at high rates of return. When we think about Insuline Medical's use of debt, we should always consider it together with cash and equity. | |
| Insuline Medical reported the revenue of 40 K. Net Loss for the year was (7.01 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Insuline Medical has accumulated about 1.15 M in cash with (7.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.86. |
Other Information on Investing in Insuline Stock
Insuline Medical financial ratios help investors to determine whether Insuline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Insuline with respect to the benefits of owning Insuline Medical security.